Bartelink H - Search Results

1

Surgical treatment and deciding definitive management policy in a premenopausal patient with early breast cancer.

Rutgers EJ, Peterse JL, Bartelink H, van Dongen JA. Rutgers EJ, et al. Among authors: bartelink h. Eur J Surg Oncol. 1994 Oct;20(5):607-9; discussion 609-10. Eur J Surg Oncol. 1994. PMID: 7926071 Review. No abstract available.

2

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

Borger JH, van Tienhoven G, Passchier DH, Hart AA, van Dongen JA, Rutgers EJ, Bartelink H. Borger JH, et al. Among authors: bartelink h. Radiother Oncol. 1992 Sep;25(1):1-11. doi: 10.1016/0167-8140(92)90188-z. Radiother Oncol. 1992. PMID: 1410583

3

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: bartelink h. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.

4

Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K. van Dongen JA, et al. Among authors: bartelink h. J Natl Cancer Inst Monogr. 1992;(11):15-8. J Natl Cancer Inst Monogr. 1992. PMID: 1627421 Clinical Trial.

5

Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.

van Tienhoven G, van Bree NA, Mijnheer BJ, Bartelink H. van Tienhoven G, et al. Among authors: bartelink h. Radiother Oncol. 1991 Dec;22(4):290-8. doi: 10.1016/0167-8140(91)90165-d. Radiother Oncol. 1991. PMID: 1792323 Review.

6

Progress in radiotherapy by treatment tailoring in head and neck cancer.

Bartelink H, Keus RB. Bartelink H, et al. Curr Opin Oncol. 1991 Jun;3(3):523-8. doi: 10.1097/00001622-199106000-00013. Curr Opin Oncol. 1991. PMID: 1892922 Review.

7

[Local recurrence following breast-conserving therapy in breast carcinoma].

van Dongen JA, Bartelink H, Peterse JL. van Dongen JA, et al. Among authors: bartelink h. Ned Tijdschr Geneeskd. 1989 Dec 30;133(52):2595-8. Ned Tijdschr Geneeskd. 1989. PMID: 2691896 Review. Dutch. No abstract available.

8

Recurrence of breast carcinoma after breast conserving treatment.

Peterse JL, van Dongen JA, Bartelink H. Peterse JL, et al. Among authors: bartelink h. Eur J Surg Oncol. 1988 Apr;14(2):123-6. Eur J Surg Oncol. 1988. PMID: 2834239

9

The impact of tumor size and histology on local control after breast-conserving therapy.

Bartelink H, Borger JH, van Dongen JA, Peterse JL. Bartelink H, et al. Radiother Oncol. 1988 Apr;11(4):297-303. doi: 10.1016/0167-8140(88)90200-9. Radiother Oncol. 1988. PMID: 2836892

10

Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.

van Dongen JA, Bartelink H, Fentiman IS, Peterse JL. van Dongen JA, et al. Among authors: bartelink h. Eur J Surg Oncol. 1987 Apr;13(2):123-5. Eur J Surg Oncol. 1987. PMID: 3030824 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters